Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$85,320,000
+$17,868,000 QoQ
Shares Held
2,000,000
+42.9% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
1.99%
of 13F equity value
Holder Rank
#27
of 712 holders
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vestal Point Capital, LP holds $216,745,000 across 3 Drug Manufacturers - General names. SNY ranks #2 (39.4% of the industry book) .
All Filings in SNY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,320,000 | 2,000,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $67,452,000 | 1,400,000 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $36,172,500 | 750,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $8,644,500 | 150,000 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $14,919,000 | 300,000 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||